Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
The formation of small Aβ42 oligomers has been implicated as a toxic species in Alzheimer disease (AD). In strong support of this hypothesis we found that overexpression of Yap1802, the yeast ortholog of the human AD risk factor, phosphatidylinositol binding clathrin assembly protein (PICALM), reduc...
Main Authors: | Sei-Kyoung Park, Kiira Ratia, Mariam Ba, Maria Valencik, Susan W. Liebman |
---|---|
Format: | Article |
Language: | English |
Published: |
Shared Science Publishers OG
2016-01-01
|
Series: | Microbial Cell |
Subjects: | |
Online Access: | http://microbialcell.com/researcharticles/inhibition-of-a%CE%B242-oligomerization-in-yeast-by-a-picalm-ortholog-and-certain-fda-approved-drugs/ |
Similar Items
-
PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
by: Xitao Zhang, et al.
Published: (2022-05-01) -
PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly
by: Zhiwei Wu, et al.
Published: (2022-12-01) -
PICALM and Alzheimer’s Disease: An Update and Perspectives
by: Kunie Ando, et al.
Published: (2022-12-01) -
PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax
by: Haimin Sun, et al.
Published: (2024-06-01) -
PICALM Rescues Endocytic Defects Caused by the Alzheimer’s Disease Risk Factor APOE4
by: Priyanka Narayan, et al.
Published: (2020-10-01)